OOIR: Observatory of International Research

Papers

(The median citation count of Current Rheumatology Reports is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Kawasaki Disease: an Update	138
COVID-19 and Myositis: What We Know So Far	92
A Review of Complement Activation in SLE	69
Systemic Lupus Erythematosus in Children and Young People	61
New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO	58
Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis—Similarities and Differences	55
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease	54
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update	53
Epidemiology of Antiphospholipid Syndrome in the General Population	51
Diagnostic Value of Muscle Ultrasound for Myopathies and Myositis	50
Update on Imaging-Based Measurement of Bone Mineral Density and Quality	44
Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides	42
Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities	41
From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention	37
The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency	36
New Criteria for Lupus	36
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease	33
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope	32
The Use of COVID-19 Vaccines in Patients with SLE	31
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component	31
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments	31
Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics	30
NETs in APS: Current Knowledge and Future Perspectives	30
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?	29
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis	28

Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens	28
Work Disability in Axial Spondyloarthritis	26
Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa	26
The Role of Musculoskeletal Ultrasound in the Rheumatoid Arthritis Continuum	26
How to Interpret Antiphospholipid Laboratory Tests	25
Lupus Vasculitis	24
Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides	24
Imaging in Vasculitis	24
Advances in the Treatment of Behcet’s Disease	23
The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis	23
Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials	23
Involvement of Macrophages and Spinal Microglia in Osteoarthritis Pain	22
Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria	22
Reactive Arthritis: Treatment Challenges and Future Perspectives	22
Management of Non-criteria Manifestations in Antiphospholipid Syndrome	22
An Update on the Diagnosis and Management of Lupus Nephritis	21
Dietary and Lifestyle-Centered Approach in Gout Care and Prevention	21
Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis	21
An Update on Antiphospholipid Syndrome	20
MicroRNAs in Systemic Lupus Erythematosus: a Perspective on the Path from Biological Discoveries to Clinical Practice	20
Treatment of Axial Spondyloarthritis: What Does the Future Hold?	20
Utility of Ultrasound and Dual Energy CT in Crystal Disease Diagnosis and Management	20
Pregnancy Outcomes in Systemic Vasculitides	20
Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future	19
Updates on the Immunopathology in Idiopathic Inflammatory Myopathies	19
Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs	19
A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?	19
Gut Microbiota in Lupus: a Butterfly Effect?	19
T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis	19
SARS-CoV-2 and Systemic Lupus Erythematosus	18
Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus	18
Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis	18
Metabolic Regulation of Tendon Inflammation and Healing Following Injury	18
Hyperuricemia, Gout, and the Brain—an Update	17
The Role of Antiphospholipid Antibodies in COVID-19	16
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis	16
Vasculitides in HIV Infection	16
Acupuncture and Chronic Musculoskeletal Pain	16
Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)	16
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist	16
Axial Psoriatic Arthritis	16
JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold?	15
Complementary and Alternative Medicine Use in Rheumatoid Arthritis	15
Impact and Management of Dysphagia in Inflammatory Myopathies	15
JAK Inhibitors: What Is New?	15
Novel Therapies for ANCA-associated Vasculitis	15
The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management	15
Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey	15
COVID-19 and Disease-Modifying Anti-rheumatic Drugs	14
Treatment of Calcinosis in Juvenile Dermatomyositis	14

Imaging of Joint and Soft Tissue Involvement in Systemic Lupus Erythematosus	14
Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment	14
Self-Management of Rheumatoid Arthritis: Mobile Applications	14
ANCA Status or Clinical Phenotype — What Counts More?	14
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?	14
Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis	14
An Update on the Pathogenesis of Skin Damage in Lupus	13
Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma	13
An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice	13
IgA Vasculitis in Adults: a Rare yet Challenging Disease	13
Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges	13
Mesangial Cells in Lupus Nephritis	13
Vaccination for Children on Biologics	13
Cardiovascular Manifestations of Systemic Vasculitides	13
Update on Uric Acid and the Kidney	13
NETosis in Rheumatic Diseases	13
Calcinosis in Systemic Sclerosis: Updates in Pathophysiology, Evaluation, and Treatment	12
A Spotlight on Drug-Induced Vasculitis	12
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature	12
Persistent Joint Pain Following Arthropod Virus Infections	12
TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals	12
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management	12
Polymyalgia Rheumatica: a Common Disease in Seniors	12
Opioid Use and Total Joint Replacement	11
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN	11
Microbial Influences of Mucosal Immunity in Rheumatoid Arthritis	11
Turning the Page in Osteoarthritis Assessment with the Use of Ultrasound	11
Beyond Giant Cell Arteritis and Takayasu’s Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers	11
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms	10
Spectrum of Spondyloarthritis Among Chinese Populations	10
Worldwide Differences in Clinical Phenotype of Axial Spondyloarthritis	10
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)	9
Autonomic Nervous System Dysregulation and Osteoarthritis Pain: Mechanisms, Measurement, and Future Outlook	9
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis	9
Anatomical Joint Form Variation in Sacroiliac Joint Disease: Current Concepts and New Perspectives	9
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update	9
Enthesitis in Psoriatic Arthritis, the Sonographic Perspective	9
Drivers of Inflammation in Psoriatic Arthritis: the Old and the New	9
Morbidity and Mortality of Large-Vessel Vasculitides	9
Localized Forms of Vasculitis	9
What Has Dual Energy CT Taught Us About Gout?	9
Radiological Findings of the Cervical Spine in Rheumatoid Arthritis: What a Rheumatologist Should Know	9
Emergence of Musculoskeletal Ultrasound Use in Pediatric Rheumatology	9
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis	9
Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis	9
Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease	9
State of the Art Management of Aortic Valve Disease in Ankylosing Spondylitis	8
Neurosarcoidosis: Phenotypes, Approach to Diagnosis and Treatment	8
COVID-19: What Do Rheumatologists Need to Know?	8
Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis	8
Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis	8
Differential Metabolome in Rheumatoid Arthritis: a Brief Perspective	8
Sonographic Features of Salivary Glands in Sjögren’s Syndrome and its Mimics	8
Trabecular Bone Score in Rheumatic Disease	8